Furthermore, transcriptomic profiling has shown decreased RIMKLB levels and increased NAT8L levels in the blood of TD patients aged 5 to 9 [66], as well as alternative splicing of RIMKLA in the blood of adult TD patients [68]. This evidence concerns the gene RIMKLA and thanatophoric dysplasia.